...
首页> 外文期刊>Journal of Virological Methods >Evaluation of accuracy of hepatitis B virus antigen and antibody detection and relationship between epidemiological factors using dried blood spot
【24h】

Evaluation of accuracy of hepatitis B virus antigen and antibody detection and relationship between epidemiological factors using dried blood spot

机译:用干血液斑点评估乙型肝炎病毒抗原和抗体检测和流行病学因子关系的评价

获取原文
获取原文并翻译 | 示例

摘要

Dried blood spots (DBS) testing might increase the access for Hepatitis B virus (HBV) diagnosis, but little is known about the performance of these assays in real life conditions. This study aims to evaluate the diagnostic accuracy of HBsAg, anti-HBc and anti-HBs detection in DBS in clinical settings and field studies and to evaluate demographic and risk behaviour according the presence of HBsAg and anti-HBc. Paired sera and DBS samples were obtained from 2309 individuals from 3 groups, defined as follows: G1: clinical setting (n = 5-19), G2: general population (n = 1305) and G3: vulnerable individuals that could be more exposed to blood contact (n = 485). Sera and DBS were tested using commercial enzyme immunoassay (EIA), with some modifications added. Using DBS samples, the specificity values were above 90 % for HBsAg and anti-HBc in all groups and for anti-HBs range from 58.6%-85%. HBsAg testing had the best performance in GI (sensitivity = 84.4 %) and among those samples that the paired serum also presented anti-HBc marker (sensitivity = 91.6 %). High sensitivity of anti-HBc testing in DBS samples was observed in GI (80.8 %) and among HBV active cases (HBsAg + /anti-HBc +) (98.4 %). Testing of anti-HBs in DBS showed the highest sensitivity in GIII (65.5 %), in previous HBV exposed and cured individuals and when serum titers were above 100 IU/mL (86.7 %). DBS samples could be used for screening and prevalence studies for HBsAg and anti-HBc, particularly in clinical settings and among HBV active cases in field studies.
机译:干血斑(DBS)测试可能会增加乙型肝炎病毒(HBV)诊断的访问,但对现实生活条件下这些测定的性能很少。本研究旨在评估临床环境研究中DBS中HBsAg,抗HBC和抗HBS检测的诊断准确性,并根据HBsAg和抗HBC评估人口统计和风险行为。从3组的2309个个体获得成对的血清和DBS样品,定义如下:G1:临床环境(n = 5-19),G2:一般人群(n = 1305)和G3:脆弱的个体可能更接触血液接触(n = 485)。使用商业酶免疫测定(EIA)测试血清和DBS,添加了一些修饰。使用DBS样品,所有基团中HBsAg和抗HBC的特异性值高于90%,抗HBS范围为58.6%-85%。 HBsAg测试在GI(敏感性= 84.4%)中具有最佳性能,以及配对血清还呈现抗HBC标记物的样品(灵敏度= 91.6%)。在GI(80.8%)和HBV活性病例(HBsAg + /抗HBC +)中观察到DBS样品中抗HBC测试的高灵敏度(HBsAg + /抗HBC +)(98.4%)。在先前的HBV暴露和固化的个体中,DBS中抗HBS的测试表现出最高敏感性(65.5%),并且当血清滴度高于100IU / ml时(86.7%)。 DBS样品可用于筛选和患有HBsAg和抗HBC的研究,特别是在临床环境中和现场研究中的HBV活性病例中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号